Sold 382 shares
of Common Stock
at $4.668 per share
(Direct)
Date: 2025-08-18 |
Code: S
| equity_swap_involved: 0 | shares_owned_after: 58,860.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
F1: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
🔍 See Tai Sandi (Executive)
Company: Lexeo Therapeutics, Inc. (LXEO)
Report Date: 2025-08-18
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,860.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes: